Johanna Borg Bruchfeld

About me

I am currently a resident in Hematology at the Hematology Department at Karolinska University Hospital and a PhD student in the Cancer Epidemiology group at KEP. MD, Linköping University, 2015.

My research focus is on sex differences in lymphoma incidence and survival working with data from the Swedish Lymphoma register.

Article: AMERICAN JOURNAL OF HEMATOLOGY. 2023;98(1):23-30

Sex differences in lymphoma incidence and mortality by subtype: A population-based study

Radkiewicz C; Bruchfeld JB; Weibull CE; Jeppesen ML; Frederiksen H; Lambe M; Jakobsen L; El-Galaly TC; Smedby KE; Wasterlid T
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(2):196-202

Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real-life outcomes of daratumumab treatment

Afram G; Gran C; Borg Bruchfeld J; Wagner AK; Hussain A; Alici E; Nahi H
Article: ACTA HAEMATOLOGICA. 2020;143(5):500-503

Rapid Complete Response to Single-Agent Bcl-2 Inhibitor Venetoclax in a Heart-Transplanted Patient with Triple Refractory Immunoglobulin Light-Chain Amyloidosis

Gran C; Bruchfeld JB; Ellin F; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(6):588-596

Translocation (11;14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration?

Gran C; Uttervall K; Bruchfeld JB; Wallblom A; Alici E; Gahrton G; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(3):247-254

Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma

Uttervall K; Bruchfeld JB; Gran C; Walinder G; Mansson R; Lund J; Gahrton G; Alici E; Nahi H

Meeting abstract: BLOOD. 2021;138:2534

Sex Differences in Lymphoma Incidence and Excess Mortality By Subtype: A Comprehensive National Study

Radkiewicz C; Bruchfeld JB; Weibull C; Lambe M; Jakobsen LH; El-Galaly TC; Smedby KE; Wästerlid T
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(3):E63-E65

Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression

Gran C; Luong V; Bruchfeld JB; Liwing J; Afram G; Lund J; Usmani S; Alici E; Nahi H
Meeting abstract: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2019;19(10):E158

Reinstating anti-tumor activity of Natural Killer cells

Caliskan C; Chrobok M; Wagner AK; Bruchfeld JB; Nahi H; Alici E

Radiumhemmets forskningsfonder

Radiumhemmet Research months for clinically active doctoral students in cancer research.

1 January 2024 - 31 December 2024